English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The current issue of CEJU brings a somewhat ambiguous paper entitled “Vitamin D and urological cancers” describing (possible) role of the vit. D in the etiology of urological cancers [1]. Indeed, last years brought numerous publications presenting that 1,25-dihydroxyvitamin D3 may alter human susceptibility to different diseases (even improve fitness) and its capability to cure or, at least, to soothe some human cancers [2, 3, 4]. Such contribution of the vit. D has been debated widely elsewhere, became trendy in contemporary medicine and engaged a great number of researches. Vit D and polymorphism of its targeted receptors have been harnessed to the etiology of: hypertension, bronchial asthma, type 2 diabetes mellitus, autoimmune disorders, cognitive decline and so forth [5]. Some studies suggest that vit. D receptor polymorphism may play a role in the prostate cancer, bladder cancer and other malicious tumours [6, 7]. Its role in the progress of the colon cancer has been scientifically proven [6]. The evidence for a protective effect of vitamin D on the risk of breast cancer has been published before. Thus, it looked that medicine found a gorgeous but simple and attainable remedy for almost everything.

Vitamin D: a 'wanted' supernatural power or a power of wishful thinking